Bispecific Antibodies in the Management of Multiple Myeloma
Oncology Today with Dr Neil Love · Dr. Neil Love
May 24, 202442m 9s
Audio is streamed directly from the publisher (dts.podtrac.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Dr Joshua Richter from the Tisch Cancer Institute, Icahn School of Medicine at Mount Sinai in New York, New York, discusses the role of bispecific antibodies in multiple myeloma.
CME information and select publications here.